medigraphic.com
Academia Mexicana de Neurología, A.C.

2005, Number 1

<< Back Next >>

Rev Mex Neuroci 2005; 6 (1)

A reflexive sight on drug abuse therapy

Souza y Machorro M

Language: Spanish
References: 91
Page: 52-66
PDF size: 142.29 Kb.


ABSTRACT

Anti-addictive therapeutics is analyzed from the point of view of addictions psychiatry, in order to promote clinical tools which support a better handling of cases. The operative binomial demand-failure makes post-treatment variables responsible of the favorable prognosis, even though it causes Burned Out Syndrome. This point of view uses its resources (risk-usefulness, cost-effectiveness) in free-of-drugs environments, qualified therapists, ad hoc activities and the fulfillment of normativity. Its operational failure recognizes characteristics in the patient (background, personality, consumption pattern, co-morbidity, internments, cronicity), of the professional dynamics (comprehension, cooperation, communication, transference and counter-transference), and the therapist (tolerance, respect, professionalism). It emphasizes the importance of consciousness about illness, development of diagnostic and sifting procedures, the handling of co-morbidity (HIV, psychophysical and sexual violence), special conditions such as senescence and the use of “vaccinations”. It concludes pointing out the participation of humanistic premises in the consolidation of a healthy way of living.


REFERENCES

  1. Souza y MM. El médico general y los problemas clínico-terapéuticos del alcoholismo. Rev Fac Med UNAM 1990; 33 (1): 13-27.

  2. Souza y MM, Mestas AJ, Turull TF, Cárdenas AJ. Historia Clínica Psiquiátrica Codificada para Alcoholismo, HCPCA. Una aportación al manejo asistencial del alcoholismo. Salud Pública de México. 1985; 17(4): 291-307.

  3. Souza y MM, Quijano BEM, Díaz BS, Guisa CVM, Lorenzo AS, Gaucin RR. Historia clínica psiquiátrica codificada para adicciones. HCPCA. 2ª. Época. Psiquiatría 1998; 14(1): 9-25.

  4. Souza y MM, Mercado CG, Martínez AJ, Arciniega TA, Solís RL, Aparicio MCJ, Basilio SGL, Tagle OI, Martínez MJ, Palacios RM, Domínguez VM. Paquete de material educativo para la capacitación en adicciones del personal de salud. Subdirección de Investigación y Adicciones. Fideicomiso para los Institutos de Niños de la Calle y las Adicciones, FINCA. Secretaría de Desarrollo Social. Gobierno del Distrito Federal. México, 2000.

  5. Souza y MM. Alcoholismo: conceptos básicos. México: Editorial El Manual Moderno; 1988.

  6. Souza y MM. Diagnóstico y tratamiento de los síndromes adictivos. México: Editorial Ciencia y Cultura Latinoamérica; 2000.

  7. Souza y MM, Martínez AJ, Mercado CG. Consideraciones sobre la farmacoterapia del alcoholismo. 2ª. Época. Psiquiatría 1999; 15(1): 12-19.

  8. Martínez MJ, Martínez AJ, Mercado CG, Souza y MM. Terapéutica integral del abuso y adicción a mariguana. 2ª. Época. Psiquiatría 1999; 15(2): 23-27.

  9. Souza y MM. I Simposio CIJ-IMSS de Diagnóstico y Tratamiento de Adicciones. Departamento de Detección Temprana y Seguimiento. Dirección de Tratamiento y Rehabilitación. Centros de Integración Juvenil, A. C. México, 1997.

  10. Hansen CF. Drug dependence-treatment takes time. Sygeplejersken 1997; 97 (27): 6-10.

  11. Merrill JC, Menza M. Treatment of drug dependence in the context of traditional disease treatment models. Psychiatr Serv 2002; 53(12): 1632-3.

  12. Miller NS, Ninonuevo FG, Klamen DL, Hoffmann NG, Smith DE. Integration of treatment and post treatment variables in predicting results of abstinence-based outpatient treatment after one year. J Psychoactive Drugs 1997; 29(3): 239-48.

  13. Heinrich CJ, Lynn LE. Improving the organization, management, and outcomes of substance abuse treatment programs. Am J Drug Alcohol Abuse 2002; 28(4): 601-22.

  14. Abstracts of the 4th European college of neuropsycho- pharmacology workshop: Neuropsychopharmacology of addiction. Nice, France, March 15-17, 2003. Eur Neuropsychopharmacol 2003; 13(1): S1-35.

  15. Elizondo LJA. Evolución histórica del concepto de alcoholismo. En: VELASCO FR. Alcoholismo. Visión integral. México: Editorial Trillas. 2ª. Reimp.; 1997.

  16. Tagle OI, Mercado CG, Martínez AJ, Martínez MJ, Souza y MM. Por qué profesionalizar la terapéutica de las adicciones. Época 2. Psiquiatría 2000; 16(3): 110-6.

  17. Morgenstern J, Bux D, Labouvie E, Blanchard KA, Morgan TI. Examining mechanisms of action in 12-step treatment: the role of 12-step cognitions. J Stud Alcohol 2002; 63(6): 665-72.

  18. Souza y MM. “Las NOM y la profesionalización de la terapéutica de las adicciones”. Simposio “Panorama actual, políticas y procedimientos clínico- terapéuticos de las adicciones”. XVII Congreso Nacional de la Asociación Psiquiátrica Mexicana, A. C. y Simposio Regional de la Asociación Psiquiátrica de América Latina. Cancún, Q. Roo 16-20 Nov., 2001.

  19. Souza y MM. Consideraciones y fundamentos para una terapéutica profesional de las adicciones. Simposio “Psiquiatría de enlace y adicciones”. XVIII Congreso Nacional Asociación Psiquiátrica Mexicana, A. C. “Salud mental: retos y perspectivas”. Monterrey, N.L. SEPT. 12-16, 2003.

  20. Carroll KM, Rounsaville BJ. Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatr Serv 2003; 54(3): 333-9.

  21. French MT, Salomé HJ, Carney M. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington. Soc Sci Med 2002; 55(12): 2267-82.

  22. Cuijpers P, Schippers GM. Introduction. Integrating substance abuse treatment and prevention in the community. Addict Behav 2002; 27(6): 847-9.

  23. Wu LT, Ringwalt CL, Williams CE. Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatr Serv 2003; 54(3): 363-9.

  24. Souza y MM. Programa General de Operación de la Clínica Hacienda San Dionisio. Tratamiento de Adicciones. San Dionisio Ocotlán, Oaxaca. México, 2003.

  25. El-Guebaly N. Twinning research and practice guidelines in the management of addictions. Can J Psychiatry 2003; 48(1): 3-4.

  26. Mojtabai R, Zivin JG. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis. Health Serv Res 2003; 38(1 Pt 1): 233-59.

  27. Diario Oficial. Norma Oficial Mexicana NOM 028-SSA2-1999 para la Prevención, Tratamiento y Control de las Adicciones. Viernes 18 de Agosto de 2000.

  28. Souza y MM. “Las NOM y la profesionalización de la terapéutica de las adicciones”. Simposio “Panorama actual, políticas y procedimientos clínico- terapéuticos de las adicciones”. XVII Congreso Nacional de la Asociación Psiquiátrica Mexicana A. C. y Simposio Regional de la Asociación Psiquiátrica de América Latina. Cancún Q. Roo 16-20 Nov., 2001.

  29. Diario Oficial. Norma Oficial Mexicana NOM-025-SSA2-1994, para la Prestación de Servicios de Salud en Unidades de Atención Integral Hospitalaria Médico-Psiquiátrica. Miércoles 15 de noviembre de 1995.

  30. Guisa CVM, Díaz BSL, Souza y MM. Adicciones, normatividad y terapéutica. En revisión editorial. Psiquiatría y Salud Integral; 2003.

  31. Braut GS. Obligations of health services in work with substance abuse. Tidsskr Nor Laegeforen 2003; 123(1): 49-51.

  32. Matheson C, Pitcairn J, Bond CM, Van Teijlingen E, Ryan M. General practice management of illicit drug users in Scotland: a national survey. Addiction 2003; 98(1): 119-26.

  33. Miller WR. A collaborative approach to working with families. Addiction 2003; 98(1): 5-6.

  34. Copello A, Orford J. Addiction and the family: is it time for services to take notice of the evidence? Addiction 2002; 97(11): 1361-3.

  35. Walsh BJ. Utilization sobriety: brief, individualized substance abuse treatment employing ideomotor questioning. Am J Clin Hypn 2003; 45(3): 217-24.

  36. Kantak KM. Vaccines against drugs of abuse: a viable treatment option? Drugs 2003; 63(4): 341-52.

  37. Dausey DJ, Desai RA. Psychiatric comorbidity and the prevalence of HIV infection in a sample of patients in treatment for substance abuse. J Nerv Ment Dis 2003;191(1): 10-7.

  38. Van Den Bosch LM, Verheul R, Schippers GM, Van Den Brink W. Dialectical behavior therapy of borderline patients with and without substance use problems. Implementation and long-term effects. Addict Behav 2002; 27(6): 911-23.

  39. Ernst E. Complementary therapies for addictions: not an alternative. Addiction 2002; 97(12): 1491-2.

  40. Lo Sasso AT, Lyons JS. The effects of co-payments on substance abuse treatment expenditures and treatment reoccurrence. Psychiatr Serv 2002; 53(12): 1605-11.

  41. Polcin DL, Prindle SD, Bostrom A. Integrating social model principles into broad-based treatment: results of a program evaluation. Am J Drug Alcohol Abuse 2002; 28(4): 585-99.

  42. Nizzoli U, Foschini V. ERIT-Italia, the Italian Federation for Professionals Working in the Field of Drug Abuse. Addiction 2002; 97(11): 1365-7.

  43. Swiatkiewicz G. Challenging the traditional treatment divisions in Poland. Addiction 2002; 97(11): 1487.

  44. Broome KM, Simpson DD, Joe GW. The role of social support following short-term inpatient treatment. Am J Addict 2002 Winter; 11(1): 57-65.

  45. Torrey WC, Drake RE, Cohen M, Fox LB, Lynde D, Gorman P, Wyzik P. The challenge of implementing and sustaining integrated dual disorders treatment programs. Community Ment Health J 2002; 38(6): 507-21.

  46. Kosten TH. Drug alcohol withdrawal management. N Eng J Med 2003; 348: 1786c-95.

  47. WHO, World Health Organization. Program on substance abuse. Approaches to treatment of substance abuse. WHO Geneva; 1993.

  48. Widlitz M, Marin DB. Substance abuse in older adults. An overview. Geriatrics 2002; 57(12): 29-34.

  49. Muller AA. GHB poisoning: three recent cases reflect the continuing danger. J Emerg Nurs 2003; 29(1): 72-4.

  50. Green-Hennessy S. Factors associated with receipt of behavioral health services among persons with substance dependence. Psychiatr Serv 2002; 53(12): 1592-8.

  51. Lo CC, Stephens RC. Arrestees’ perceived needs for substance-specific treatment: exploring urban-rural differences. Am J Drug Alcohol Abuse 2002; 28(4): 623-42.

  52. Gariti P, Alterman A, Mulvaney F, Mechanic K, Dhopesh V, Yu E, Chychula N, Sacks D. Nicotine intervention during detoxification and treatment for other substance use. Am J Drug Alcohol Abuse 2002; 28(4): 671-9.

  53. Souza y MM, Martinez AJ, Martínez MJ, Mercado CG, Tagle OI. Craving, adicción etílica y terapéutica. Archivos de Neurociencias México 2000; 5(4): 201-4.

  54. Gariti P, Alterman A, Mulvaney F, Mechanic K, Dhopesh V, Yu E, Chychula N, Sacks D. Nicotine intervention during detoxification and treatment for other substance use. Am J Drug Alcohol Abuse. 2002; 28(4): 671-9.

  55. Lyman MJ, Gidycz CA, Lynn SJ. Unacknowledged versus acknowledged rape victims: situational factors and posttraumatic stress. J Abnorm Psychol 1996; 105(1): 124-31.

  56. Van Heeringen C, Vincke J. Suicidal acts and ideation in homosexual and bisexual young people: a study of prevalence and risk factors. Soc Psychiat Epidemiol 2000; 35(11): 494-9.

  57. Organización Mundial de la Salud. OMS. Décima Revisión Internacional de la Clasificación de Enfermedades. Capítulo V. Trastornos Mentales, Conductuales y del Desarrollo. OMS, Ginebra; 1993.

  58. Guisa CVM, Díaz BSL, Souza y MM. A propósito de la relación entre adicciones y delincuencia. 2ª. Época. Psiquiatría 2003; 19(1): 14-27.

  59. Carroll KM, Rounsaville BJ. On beyond urine: clinically useful assessment instruments in the treatment of drug dependence. Behav Res Ther 2002; 40(11): 1329-44.

  60. Weisner C, Matzger H, Tam T, Schmidt L. Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance. J Stud Alcohol 2002; 63(6): 673-82.

  61. Rosen CS, Ouimette PC, Sheikh JI, Gregg JA, Moos RH. Physical and sexual abuse history and addiction treatment outcomes. J Stud Alcohol 2002; 63(6): 683-7.

  62. Ritsher JB, Mckellar JD, Finney JW, Otilingam PG, Moos RH. Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders. J Stud Alcohol 2002; 63(6): 709-15.

  63. Chychula NM, Sciamanna C. Help substance abusers attain and sustain abstinence. Nurse Pract 2002; 27(11): 30-47.

  64. Nordlie E, Vøyvik T, Aasland OG. Treatment offered to drug addicts. Tidsskr Nor Laegeforen 2002; 122(25): 2455-7.

  65. Alderman C. Open house detox. Nurs Stand 2002; 17(4): 16-7.

  66. Rosenker DC. Adolescent substance abuse: tools counselors can use. Behav Health Tomorrow 2002; 11(5): SR27.

  67. O’Farrell TJ, Fals-Stewart W. Behavioral couples and family therapy for substance abusers. Curr Psychiatry Rep 2002; 4(5): 371-6.

  68. Kacker R. From no interest to special interest: a personal reflection on the RCGP certificate in substance misuse. Br J Gen Pract 2002; 52(483): 866.

  69. Berglund M. More about substance abuse in medical education. A joint European curriculum under development. Lakartidningen 2002; 99(43): 4250-1.

  70. Johnson KW, Young LC, Suresh G, Berbaum ML. Drug abuse treatment training in Peru. A social policy experiment. Eval Rev 2002; 26(5): 480-519.

  71. U.S. Goverment Printing Office, NON-P.H.S. Educational Measurement. Health Personnel/education. Human. Peru. Attitude of Health Personnel. Community Health Centers/manpower. Comparative Study. Program Development/standards. Program Evaluation. Support; 2002.

  72. Riggs PD, Davies RD. A clinical approach to integrating treatment for adolescent depression and substance abuse. J Am Acad Child Adolesc Psychiatry 2002; 41(10): 1253-5.

  73. Mendyk SL, Fields DW. Acute psychotic reactions: consider “dip dope” intoxication. J Emerg Nurs 2002; 28(5): 432-5.

  74. Komiyayama T. Protracted withdrawal symptoms and therapy for alcohol and drug dependence. Nihon Shinkei Seishin Yakurigaku Zasshi 2002; 22(5): 199-200.

  75. Arkansas Cares. Integrated services for mothers with dual diagnoses and their children. Arkansas Center for Addictions Research, Education, and Services. Psychiatr Serv 2002; 53(10): 1311-3.

  76. Martin J. Produits, société et prises en charge de l’addiction: quelques enseignements d’un quart de siècle de santé publique. Rev Med Suisse Romande 2002; 122(10): 513-8.

  77. Watson AC, Corrigan PW. Responsibility and addiction. Psychiatr Serv 2002; 53(10): 1327-8.

  78. Peyser H. Responsibility and addiction. Psychiatr Serv 2002; 53(10): 1327.

  79. Merrill JO, Marlatt GA. Health care workers and addiction. N Engl J Med 2002; 347(13): 1044-5.

  80. Kantak KM. Vaccines against drugs of abuse: a viable treatment option? Drugs 2003; 63(4): 341-52.

  81. Oficina de las Naciones Unidas Contra la Droga y el Delito. Tratamiento contemporáneo del abuso de drogas: análisis de las pruebas científicas. Naciones Unidas. NewYork, 2003.

  82. Ernst E. Complementary therapies for addictions: not an alternative. Addiction 2002; 97(12): 1491-2.

  83. Broome KM, Simpson DD, Joe GW. The role of social support following short-term inpatient treatment. Am J Addict 2002 Winter; 11(1): 57-65.

  84. Torrey WC, Drake RE, Cohen M, Fox LB, Lynde D, Gorman P, Wyzik P. The challenge of implementing and sustaining integrated dual disorders treatment programs. Community Ment Health J 2002; 38(6): 507-21.

  85. Souza y MM, Turull TF, Cárdenas AJ. Los enfoques sociomédicos del alcoholismo y los modelos de abordaje de la problemática del consumo del alcohol. Rev Fac Med Mex 1984; 27(11): 11-17.

  86. Widlitz M, Marin DB. Substance abuse in older adults. An overview. Geriatrics 2002; 57(12): 29-34.

  87. Green-Hennessy S. Factors associated with receipt of behavioral health services among persons with substance dependence. Psychiatr Serv 2002; 53(12): 1592-8.

  88. Merrill JC, Menza M. Treatment of drug dependence in the context of traditional disease treatment models. Psychiatr Serv 2002; 53(12): 1632-3.

  89. Lo Sasso AT, Lyons JS. The effects of copayments on substance abuse treatment expenditures and treatment reoccurrence. Psychiatr Serv 2002; 53(12): 1605-11.

  90. French MT, Salomé HJ, Carney M. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington. Soc Sci Med 2002; 55(12): 2267-82.

  91. Gariti P, Alterman A, Mulvaney F, Mechanic K, Dhopesh V, Yu E, Chychula N, Sacks D. Nicotine intervention during detoxification and treatment for other substance use. Am J Drug Alcohol Abuse. 2002; 28(4): 671-9.




2020     |     www.medigraphic.com